Elemental Advisors Launches PSYK ETF Focused on the Medical Psychedelics Industry

Key Facts

The Index will be principally comprised of companies that have, or are expected to have, a significant part of their business involved in the research, development, production and/or use of psychedelic-based pharmaceuticals and therapeutics.
About Elemental Advisors Inc. Elemental Advisors was founded by individuals with decades of experience in capital markets to provide investors exposure to a diversified portfolio of companies engaged in cutting-edge medical research in drugs and therapies that may be disruptive to the medical industry.
The Fund is considered to be non-diversified, which means that it may invest more of its assets in the securities of a single issuer or a smaller number of issuers than if it were a diversified fund.
As a result, the Fund may be more exposed to the risks associated with and developments affecting an individual issuer or a smaller number of issuers than a fund that invests more widely.